EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | +4.0% | 933 | 0.0% | 0.00% | – |
| Q4 2022 | $25 | -99.9% | 933 | 0.0% | 0.00% | – |
| Q3 2022 | $25,000 | -39.0% | 933 | 0.0% | 0.00% | – |
| Q2 2022 | $41,000 | +78.3% | 933 | +85.1% | 0.00% | – |
| Q1 2020 | $23,000 | -97.5% | 504 | -96.7% | 0.00% | -100.0% |
| Q4 2019 | $909,000 | +6.3% | 15,122 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $855,000 | +408.9% | 15,122 | +400.4% | 0.01% | +500.0% |
| Q2 2019 | $168,000 | -86.4% | 3,022 | -83.1% | 0.00% | -88.9% |
| Q3 2018 | $1,239,000 | – | 17,877 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |